NOVA
NOVA's revenue rose 31.0% to $881 million in fiscal 2025. Its operating margin was 28.8%, up from 27.9% a year earlier. Free cash flow was $218 million, down 0.1%. It paid out $35 million in dividends and buybacks, 16% of free cash flow. The diluted share count rose 2.1%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Income statement
From fiscal 2016 to 2025, earnings per share grew 41.5% a year and net income 44.2% a year, as new shares raised the share count by 19% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 349 | 278 | 324 | 375 | 536 |
| Debt incl. finance leases | 0 | 196 | 0 | 0 | 732 |
| Net debt (negative means net cash) | −349 | −82 | −324 | −375 | 195 |
| Net debt to EBITDA | −2.9x | −0.5x | −2.2x | −1.8x | 0.7x |
| Debt to equity | 0.0x | 0.3x | 0.0x | 0.0x | 0.6x |
| Interest coverage | 26.6x | 117.0x | 103.0x | 146.5x | 127.0x |
| Current ratio | 2.0x | 4.6x | 2.2x | 2.3x | 6.3x |
| Quick ratio | 1.7x | 3.7x | 1.8x | 1.9x | 5.5x |
Cash flow
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 4 of 9 | 7 of 9 | 5 of 9 |
| Rule of 40 | 11.3% | 62.2% | 55.7% |
| Altman Z'' | 6.85 | 7.31 | 6.81 |
| Accruals ratio | 1.2% | −4.1% | 0.7% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Pass |
| Cash from operations exceeds net income | Fail | Pass | Fail |
| Debt fell relative to assets | Pass | Fail | Fail |
| Current ratio rose | Fail | Pass | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 4 of 9 | 7 of 9 | 5 of 9 |
Compare
Put NOVA side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| NOVA | FY25 | 31.0% | 28.8% | 24.8% | 21.0% | 0.7x | 5 | |
| ACM Research | FY25 | 15.2% | 12.1% | −7.4% | 8.7% | −4.1x | 2 | Compare |
| Photronics | FY25 | −2.0% | 24.5% | 7.0% | 19.1% | −2.1x | 6 | Compare |
| Axcelis Technologies | FY25 | −17.6% | 14.2% | 12.8% | — | — | — | Compare |
| Ichor | FY25 | 11.6% | −4.1% | −0.7% | −4.4% | — | 4 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 164 | 222 | 251 | 225 | 269 | 416 | 571 | 518 | 672 | 881 |
| Revenue growth | 10.4% | 35.4% | 13.1% | −10.4% | 19.8% | 54.5% | 37.2% | −9.2% | 29.8% | 31.0% |
| Gross profit | 75 | 131 | 145 | 122 | 151 | 235 | 317 | 293 | 387 | 505 |
| Research and development | 35 | 39 | 46 | 44 | 53 | 66 | 90 | 88 | 110 | 143 |
| Operating income | 10 | 58 | 60 | 36 | 56 | 112 | 150 | 132 | 188 | 254 |
| Net income | 10 | 46 | 54 | 35 | 48 | 93 | 140 | 136 | 184 | 259 |
| Diluted EPS (US$) | 0.35 | 1.63 | 1.89 | 1.23 | 1.65 | 3.12 | 4.43 | 4.28 | 5.75 | 7.96 |
| Diluted shares (millions) | 28 | 28 | 29 | 29 | 29 | 30 | 32 | 32 | 32 | 33 |
| Cash flow | ||||||||||
| Cash from operations | −4 | 62 | 37 | 41 | 60 | 132 | 120 | 124 | 235 | 246 |
| Capital expenditure | 3 | 6 | 4 | 21 | 6 | 5 | 21 | 17 | 17 | 28 |
| Free cash flow | −7 | 56 | 33 | 19 | 54 | 127 | 98 | 106 | 218 | 218 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 1 | 0 | 5 | 7 | 12 | 0 | 21 | 0 | 30 | 35 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 78 | 0 | 0 | 56 |
| Stock-based compensation | 3 | 3 | 4 | 5 | 7 | 10 | 17 | 18 | 25 | 26 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 91 | 149 | 176 | 186 | 424 | 349 | 278 | 324 | 375 | 536 |
| Debt incl. finance leases | — | — | — | — | 179 | 0 | 196 | 0 | 0 | 732 |
| Total assets | 219 | 283 | 333 | 400 | 656 | 805 | 984 | 1,134 | 1,390 | 2,360 |
| Total liabilities | 44 | 56 | 53 | 86 | 284 | 331 | 397 | 383 | 463 | 1,042 |
| Shareholders' equity | 175 | 227 | 281 | 314 | 372 | 474 | 587 | 751 | 928 | 1,318 |
| Margins and ratios | ||||||||||
| Gross margin | 45.9% | 59.1% | 57.8% | 54.2% | 56.1% | 56.6% | 55.5% | 56.6% | 57.6% | 57.4% |
| Operating margin | 6.2% | 26.1% | 24.1% | 16.2% | 20.6% | 27.0% | 26.3% | 25.5% | 27.9% | 28.8% |
| Net margin | 5.9% | 20.9% | 21.6% | 15.6% | 17.8% | 22.4% | 24.6% | 26.3% | 27.3% | 29.4% |
| Free cash flow margin | −4.5% | 25.0% | 13.3% | 8.6% | 20.0% | 30.6% | 17.2% | 20.5% | 32.4% | 24.8% |
| Rule of 40 (growth + FCF margin) | 5.9% | 60.5% | 26.4% | −1.8% | 39.8% | 85.1% | 54.4% | 11.3% | 62.2% | 55.7% |
| Return on capital | — | — | — | — | — | 76.1% | 42.1% | 25.0% | 32.5% | 21.0% |
| Return on equity | 5.7% | 23.1% | 21.4% | 11.8% | 14.0% | 22.0% | 26.4% | 20.4% | 21.9% | 23.1% |
| Return on assets | 4.5% | 18.5% | 17.6% | 9.6% | 9.1% | 12.8% | 15.7% | 12.9% | 14.6% | 13.8% |
| Net debt to EBITDA | — | — | — | — | −3.8x | −2.9x | −0.5x | −2.2x | −1.8x | 0.7x |